Arrowhead Pharmaceuticals, Inc. - Common Stock — 현금 흐름 (NASDAQ:ARWR)

Financials

영업활동으로 인한 현금 -95.39 M171.22 M-136.13 M-153.89 M-462.85 M179.55 M -36.31 M 투자 활동으로 인한 현금 -240.78 M-141.68 M-5.42 M-96.16 M-420.07 M-129.29 M -704.01 M 재무활동으로 인한 현금 257.95 M11.3 M65.19 M253.05 M870.52 M74.01 M 741.96 M 잉여 현금 흐름 -95.39 M171.22 M-136.13 M-153.89 M-462.85 M156.89 M -50.87 M

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

ARWR

Financials

Arrowhead Pharmaceuticals, Inc. - Common Stock

뉴스

These Are The Upcoming Catalysts For Crispr Therapeutics Stock (NASDAQ:CRSP)

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2026 Earnings Call Transcript

Sarepta's Q1 Earnings & Sales Beat Estimates, '26 Outlook Maintained

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone

Stocks Fall as Iran Refuses to Attend Peace Talks

Stocks Erase Early Gains as Crude Prices Jump on Iran Concerns

Stocks Supported by Signs Iran Will Attend Peace Talks

Wave Life Sciences Crashes 55% As 'Body Composition' Fat-Loss Drug Underwhelms

Arrowhead Pharmaceuticals: Transition Phase With Moderate Upside Ahead (NASDAQ:ARWR)

Sarepta Plans FDA Filings Seeking Full Approval for Two DMD Therapies

SRPT Stock Up as Enrollment Begins in DMD Gene Therapy Safety Study